Literature DB >> 32878852

Primary mixed large cell neuroendocrine and high grade serous carcinoma of the endometrium.

Liesel Elisabeth Hardy1,2, Zia Chaudry2,3, King Wan4, Chloe Ayres4.   

Abstract

Endometrial large-cell neuroendocrine carcinoma admixed with a high-grade serous (HGS) adenocarcinoma is extremely rare with only one reported case in the literature. We present the second reported case in a 47-year-old woman who presented with abdominal pain, distension and loss of weight. On examination she had a fixed pelvic mass and vascular left vaginal mass. Imaging confirmed a 13 cm solid cystic rectouterine pelvic mass, omental disease and retroperitoneal lymphadenopathy. She underwent a modified posterior exenteration, partial posterior vaginectomy, omentectomy and Hartmanns procedure with suboptimal debulking. Histopathology revealed a stage 4B mixed carcinoma with large cell neuroendocrine (70%) and HGS carcinoma (30%). Eight cycles of adjuvant cisplatin and paclitaxel were given with a complete radiological and biochemical response after 7 months. Unfortunately, she developed widespread recurrence at 9 month and was offered second line chemotherapy. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  chemotherapy; gynecological cancer; obstetrics and gynaecology; radiotherapy

Mesh:

Year:  2020        PMID: 32878852      PMCID: PMC7470651          DOI: 10.1136/bcr-2020-234977

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  A detailed morphological and immunohistochemical comparison of primary endometrial and tubo-ovarian high-grade serous carcinomas and their corresponding omental metastases.

Authors:  Sukeerat Ruba; Dorota Doherty; Colin J R Stewart
Journal:  Pathology       Date:  2019-12-20       Impact factor: 5.306

2.  Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA.

Authors:  Tadashi Terada
Journal:  Pathol Res Pract       Date:  2010-02-26       Impact factor: 3.250

Review 3.  Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document.

Authors:  Ginger J Gardner; Diane Reidy-Lagunes; Paola A Gehrig
Journal:  Gynecol Oncol       Date:  2011-07       Impact factor: 5.482

4.  Rapidly progressing large-cell neuroendocrine carcinoma arising from the uterine corpus: A case report and review of the literature.

Authors:  Aya Kobayashi; Tamaki Yahata; Sakiko Nanjo; Mika Mizoguchi; Madoka Yamamoto; Yasushi Mabuchi; Shigetaka Yagi; Sawako Minami; Kazuhiko Ino
Journal:  Mol Clin Oncol       Date:  2017-04-27

5.  Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.

Authors:  Nicholas J Mulvany; David G Allen
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

Review 6.  Large cell neuroendocrine carcinoma of the uterine corpus metastatic to brain and lung: case report and review of the literature.

Authors:  Y Erhan; Y Dikmen; M S Yucebilgin; O Zekioglu; L Mgoyi; M C Terek
Journal:  Eur J Gynaecol Oncol       Date:  2004       Impact factor: 0.196

Review 7.  Neuroendocrine tumors of the gynecologic tract: select topics.

Authors:  Marjan Rouzbahman; Blaise Clarke
Journal:  Semin Diagn Pathol       Date:  2013-08       Impact factor: 3.464

Review 8.  Small cell neuroendocrine carcinoma of the endometrium.

Authors:  K H van Hoeven; J A Hudock; J M Woodruff; M J Suhrland
Journal:  Int J Gynecol Pathol       Date:  1995-01       Impact factor: 2.762

9.  Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus.

Authors:  Shohreh Shahabi; Ilenia Pellicciotta; June Hou; Sarah Graceffa; Gloria S Huang; Robert N Samuelson; Gary L Goldberg
Journal:  Rare Tumors       Date:  2011-10-11

10.  Neuroendocrine Tumors of the Female Reproductive Tract: A Literature Review.

Authors:  Yi Kyeong Chun
Journal:  J Pathol Transl Med       Date:  2015-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.